Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EDP170
- Development stage
- Preclinical
- Lead developer
- Genor Biopharma
- Modality
- Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Single-strand DNA → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Modified DNA Oligonucleotides → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
01
Overview
EDP170 is an antisense oligonucleotide (ASO) therapeutic candidate currently in development by Genor Biopharma. It is designed to target an undisclosed molecular pathway for the treatment of liver disease. As part of Genor's oligonucleotide platform, EDP170 utilizes ASO technology to modulate gene expression, though specific details regarding its target, mechanism of action, or the particular type of liver pathology it addresses have not been publicly released. The drug is part of a broader pipeline at Genor Biopharma that includes both antibody-based biologics and other oligonucleotide therapies such as siRNA.
Beyond the preview
Go deeper on EDP170.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EDP170.